Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM ORCHID PHARMA NGL FINE CHM/
ORCHID PHARMA
 
P/E (TTM) x 26.8 64.5 41.5% View Chart
P/BV x 4.2 6.5 64.9% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NGL FINE CHM   ORCHID PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-24
ORCHID PHARMA
Mar-24
NGL FINE CHM/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs2,4251,359 178.5%   
Low Rs1,211371 326.2%   
Sales per share (Unadj.) Rs548.0161.5 339.2%  
Earnings per share (Unadj.) Rs66.918.7 356.7%  
Cash flow per share (Unadj.) Rs85.725.3 338.8%  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs425.0230.6 184.3%  
Shares outstanding (eoy) m6.1850.72 12.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.35.4 61.9%   
Avg P/E ratio x27.246.1 58.9%  
P/CF ratio (eoy) x21.234.2 62.0%  
Price / Book Value ratio x4.33.8 114.0%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m11,23243,872 25.6%   
No. of employees `000NANA-   
Total wages/salary Rs m451696 64.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,3878,194 41.3%  
Other income Rs m141311 45.4%   
Total revenues Rs m3,5288,505 41.5%   
Gross profit Rs m5371,108 48.5%  
Depreciation Rs m116332 35.0%   
Interest Rs m18167 10.8%   
Profit before tax Rs m544919 59.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m131-31 -420.0%   
Profit after tax Rs m413951 43.5%  
Gross profit margin %15.913.5 117.3%  
Effective tax rate %24.1-3.4 -709.7%   
Net profit margin %12.211.6 105.1%  
BALANCE SHEET DATA
Current assets Rs m2,1277,908 26.9%   
Current liabilities Rs m8662,600 33.3%   
Net working cap to sales %37.264.8 57.5%  
Current ratio x2.53.0 80.7%  
Inventory Days Days7050 140.9%  
Debtors Days Days966871 110.9%  
Net fixed assets Rs m1,4297,631 18.7%   
Share capital Rs m31507 6.1%   
"Free" reserves Rs m2,59511,187 23.2%   
Net worth Rs m2,62611,695 22.5%   
Long term debt Rs m71,204 0.6%   
Total assets Rs m3,55515,539 22.9%  
Interest coverage x31.16.5 478.4%   
Debt to equity ratio x00.1 2.8%  
Sales to assets ratio x1.00.5 180.7%   
Return on assets %12.17.2 168.6%  
Return on equity %15.78.1 193.5%  
Return on capital %21.38.4 253.4%  
Exports to sales %70.380.5 87.3%   
Imports to sales %13.630.4 44.6%   
Exports (fob) Rs m2,3816,594 36.1%   
Imports (cif) Rs m4592,489 18.5%   
Fx inflow Rs m2,4096,594 36.5%   
Fx outflow Rs m5092,705 18.8%   
Net fx Rs m1,9003,889 48.9%   
CASH FLOW
From Operations Rs m2051,260 16.2%  
From Investments Rs m-268-3,120 8.6%  
From Financial Activity Rs m-111,670 -0.6%  
Net Cashflow Rs m-74-190 39.1%  

Share Holding

Indian Promoters % 72.7 69.8 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 20.2 0.1%  
FIIs % 0.0 1.9 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.3 30.2 90.4%  
Shareholders   14,575 36,363 40.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs Orchid Pharma Share Price Performance

Period NGL FINE CHM Orchid Pharma S&P BSE HEALTHCARE
1-Day -0.63% 1.73% 0.64%
1-Month -10.82% 21.05% -0.82%
1-Year -6.61% 154.51% 42.79%
3-Year CAGR -12.72% 55.54% 20.12%
5-Year CAGR 32.94% 142.14% 26.10%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 72.7% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 2.6%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.